30 closest matches · ranked by relevance
Breast Cancer
Primary: Gain in Specificity at Fixed 98% Sensitivity (fSp) — 38.22; 47.20 % benign+TPB masses correctly identified — p=0.0268
Breast Cancer
Primary: Specificity Difference Between Imagio Optoacoustic Plus Gray-scale (OA/US) vs Imagio Gray-scale Ultrasound (IUS) — 14.9 % benign+TPB masses correctly Id'd
Breast Cancer
Primary: OA/US Specificity (Downgrade (%) for BI-RADS 4A & 4B) of Benign Masses — 41.1 percentage of masses
Breast Health
Primary: Number of Participants With Acceptable Overall Clinical Image Quality — 14; 9 Participants
Prostate Neoplasm
Primary: The Proportion of Men With a Positive MRI Defined by a Score of 3 or Greater — 17.7 Percentage of participants
Breast Cancer Stage
Primary: Number of Participants With Imagio Image Sets Collected — 38 Participants
Cardiac Arrhythmia
Primary: The Proportion of MRI Scans From Pacemakers or CRT-Ps Providing Sufficient Image Quality to Allow for a Diagnostic Interpretation. — 129 MRI Scans
Breast Cancer
Primary: Number of Participants for Whom Study Image Data Were Collected — 642; 124; 244 Participants
Breast Biopsy
Primary: Impact of US-guided DOT on the Potential Reduction of Benign Biopsies as Measured by Comparing the Reads With a Non- Suspicious Assessment of Conventional Imaging (CI)…
Scapholunate Interosseous Ligament Injury
Primary: Equivalency of 4DCT-based Treatment Plan to Arthroscopic-based Treatment Plan. — 5; 14; 11 Participants
Multiple Myeloma · Smoldering Multiple Myeloma · Monoclonal Gammopathy of Undetermined Significance
Primary: Count of Participants With Positive and Negative 18F-FDG PET CT and F18-NaF PET CT Imaging Results in Individuals With MGUS, SMM, and MM. — 0; 1; 5; 10 Participants
Breast Cancer
Primary: Beta of CT Coronal View — 1.75 power-law slope(B)
Stroke, Acute
Primary: Ischemic Stroke Diagnostic Accuracy (CBCT Versus CT) — 90; 90 percentage of gold standard
Arteriovenous Malformations · Aneurysm · Stenosis
Primary: Image Quality. For Each Included Participant 2 Images (1 AlluraXper; 1 AlluraClarity) Were Evaluated. — 9.4; 11.9; 13.1; 14.1 Scores on a scale
Prostate Cancer
Primary: Compare the Biodistribution of 11C-acetate Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Tumor and Non Tumorous Regions of the Prostate — 4.4…
CT Scanners X Ray
Primary: Image Quality — 4.53; 4.44; 4.63 units on a scale
Prostate Cancer · Cancer of the PROSTATE · Prostatic Neoplasm
Primary: Keyword Description of Each Biopsy Sample — 89 percentage significant cancers detected
Solitary Pulmonary Nodules
Primary: Radlex Scale for Diagnostic Quality Ratings - DE Predicate PA Chest — 3.4540 units on a scale
Breast Carcinoma
Primary: Rate of Detection of Invasive Cancers — 9; 14 Participants
Breast Cancer
Primary: Efficacy Based on the Area Under the Receiver Operating Characteristic (ROC) Curve in Breasts Analyzed With DBT as an Adjunct to FFDM vs. FFDM Alone — 0.8527; 0.7516…
Peripheral Artery Disease
Primary: Quality of Images — .702; .872; .10; .743 Clear imaging field (CIF) proportion
Breast Cancer
Primary: Sensitivity on the Per Patient Level — 25; 27 participants
Recurrent Colon Cancer · Recurrent Rectal Cancer · Stage IIA Colon Cancer
Primary: Maximum Standardized Uptake Value (SUVmax) in Physiologic Regions and Fluorodeoxyglucose (FDG) Avid Lesions in Participants Where PET-CT Was Performed Prior to the…
Prostate Cancer
Primary: Number of Participants With Clinically Significant Cancer — 38; 31 Participants
Ischemic Heart Disease
Primary: Diagnosis of IHD at Invasive Coronary Angiography and FFR Measurement — 140 participants
Malignant Solid Neoplasm
Primary: Contrast to Noise Ratio — 3.2 Ratio — p=< 0.05
Fracture
Primary: Sensitivity — 96.7 percent of scans with a fracture
Spinal Injuries
Primary: Radlex Scale for Diagnostic Capability Ratings - Cedara Accustitch Software (Predicate) — 3.01 units on a scale — p=0.02
Peripheral Artery Disease
Primary: Visualization of Vessel Morphology: Layered Structure — 1.61; 1.49 score on a scale
Cholecystitis · Hepatocellular Carcinoma · Liver Metastases
Primary: Quantitative Assessment - Bile Duct-to-liver Fluorescence Intensity Ratio — 2.7; 0.7 ratio